Greg Blake
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Greg Blake
Executive Director / Zelira Therapeutics
Mr Blake has led the strategic development and commercialization of several products across a range of therapeutic categories. Throughout his near 20 years working in healthcare Greg has built a foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as General Manager led the company through the establishment of the pre-launch pathway and commercialization planning for both domestic and international markets.
Lists and Charts
Total Shareholder Return as at 30/08/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1153rd | Zelira Therapeutics | -29% | -42% |
1746 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Zelira Therapeutics | $1.0m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEW ROLE: Executive Director, Z Energy | 14 Aug 2024 |
| NEW ROLE: Executive Director, Zelira Therapeutics | 14 Aug 2024 |
